期刊文献+

前列腺特异性抗原在老年前列腺疾病中的诊断价值 被引量:3

Diagnostic Value of Prostate Specific Antigen in Elderly Patients with Prostate Diseases
下载PDF
导出
摘要 目的探究游离前列腺特异性抗原(fPSA)、总前列腺特异性抗原(tPSA)和fPSA/tPSA比值在前列腺癌和良性前列腺增生老年患者中的诊断价值。方法采用罗氏e411电化学发光免疫定量分析仪、Free PSA及Total PSA试剂盒检测前列腺癌(PCa)组(45例)、前列腺增生(BPH)组(89例)、正常对照组(194例)血清tPSA、fPSA的含量,并计算fPSA/tPSA比值。结果PCa组和BPH组的fPSA值和tPSA值均高于正常对照组,PCa组fPSA/tPSA比值低于正常对照组(P均<0.001);PCa组的fPSA值和tPSA值均高于BPH组,fPSA/tPSA比值低于BPH组(P均<0.001)。结论tPSA、fPSA和fPSA/tPSA比值可以区分老年男性前列腺癌和良性前列腺增生。 Objective To study the diagnostic value of free prostate specific antigen(fPSA),total prostate specific antigen(tPSA)and fPSA/tPSA ratio in 60-90-year-old men with prostate cancer or benign prostatic hyperplasia.Methods The serum levels of tPSA and fPSA in prostate cancer(PCa)group(45 cases),benign prostatic hyperplasia(BPH)group(89 cases)and normal control group(194 cases)were detected by Roche e411 electrochemiluminescence immunoassay analyzer.fPSA,tPSA and the fPSA/tPSA ratio was calculated.Results Results showed that the values of fPSA and tPSA in PCa and BPH groups were higher than those in normal control group,the values of fPSA and tPSA in PCa group were higher than those in BPH group(P all<0.001).The value of fPSA/tPSA in PCa group was lower than those in normal control group,the value of fPSA/tPSA in PCa group was lower than those in BPH group(P all<0.001).Conclusion The valce of fPSA,tPSAand fPSA/tPSA can distinguish prostate cancer or benign prostatic hyperplasia.
作者 宋佳卉 孙萍 SONG Jiahui;SUN Ping(Ningxia Medical University,Yinchuan750004,China;Third People’s Hospital of Ningxia Hui Autonomous Region,Yinchuan750004,China)
出处 《宁夏医科大学学报》 2019年第9期954-956,共3页 Journal of Ningxia Medical University
关键词 前列腺癌 前列腺增生 游离前列腺特异性抗原 总前列腺特异性抗原 prostate cancer benign prostatic hyperplasia free prostate specific antigen total prostate specific antigen
  • 相关文献

参考文献8

二级参考文献88

  • 1彭涛,伍兵,肖建明.磁共振波谱与扩散加权成像技术诊断前列腺癌的比较研究[J].四川大学学报(医学版),2013,44(5):827-831. 被引量:6
  • 2王志平,陈一戎,刘国栋.花粉提取物对前列腺增生细胞作用的研究[J].中华泌尿外科杂志,1995,16(12):732-733. 被引量:15
  • 3曹希亮,高江平,许承斌,唐杰,文载律,洪宝发.前列腺穿刺病理组织学类型在不同PSA水平中的分布[J].临床泌尿外科杂志,2007,22(2):109-110. 被引量:10
  • 4Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013 [J] . CA Cancer J Clin, 2013, 63 ( 1 ) : 11-30. 被引量:1
  • 5Coleman RE. Adjuvant bisphosphonates in breast cancer : Are we witnessing the emergence of a new therapeutic strategy? [ J ] - Eur J Cancer, 2009, 45 ( 11 ) : 1909-1915. 被引量:1
  • 6Fleisch H, Russell RG, Francis MD. Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo [ J ] . Science, 1969, 165 ( 3899 ) : 1262-1264. 被引量:1
  • 7Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [ J ] . N Engl J Med, 2007, 356 ( 18 ) : 1809-1822. 被引量:1
  • 8Henneman ZJ, Nancollas GH, Ebetino FH, et al. Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro [ J ] . J Biomed Mater Res A, 2008, 85 ( 4 ) : 993-1000. 被引量:1
  • 9Green JR. Antitumor effects of bisphosphonates [ J ] . Cancer, 2003, 97 ( $3 ) : 840-847. 被引量:1
  • 10Boissier S, Ferreras M, Peyruehand O, et al. Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases [ J ] . Cancer Res, 2000, 60 ( 11 ) : 2949-2954. 被引量:1

共引文献56

同被引文献34

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部